SCHERING-PLOUGH SELECTS COMPOUND FOR FURTHER DEVELOPMENT

Schering-Plough has revealed that it is to further develop a compound for the treatment of respiratory disease identified in the company's collaboration with Pharmacopeia.

Pharmaceutical Business Review (http://www.pharmaceutical-business-review.com/article_news.asp?guid=32F9CC5B-B048-4CDD-B167-216CA22DB692)